Bypass Management · 8 min read

Heparin Resistance On Bypass

A practical review of the problem behind the low ACT: when to think of true heparin resistance, what confuses the picture, and how to keep the response structured.

Published 2026-04-11 · Last reviewed 2026-04-12

Learning objectives

Understand why a low ACT after heparin is a problem frame, not automatically a diagnosis.
Identify the main contributors that can make the response to heparin appear inadequate on bypass day.
Use a structured response model that keeps assay limitations, antithrombin biology, and local protocol aligned.

Key takeaways

Heparin resistance is often discussed as a single entity, but the bedside problem is usually “unexpected anticoagulation response” until you clarify why.
ACT alone can mislead if you stop thinking about assay context, heparin dose delivery, haemodilution, and antithrombin status.
A calm protocol-driven response is better than repeated blind dosing.

Start with the right question

The practical problem is not simply “the ACT is low.” The better question is “why is the anticoagulation response not matching what we expected after this dose, in this patient, using this assay?”

That framing matters because it prevents people from collapsing a measurement problem, a biology problem, and a delivery problem into one label too early.

Why the response can look inadequate

True biological resistance is only part of the picture. Low antithrombin activity, recent heparin exposure, severe inflammation, high thrombin generation, sampling issues, or device-specific ACT behaviour can all distort the bedside impression.

That means the perfusionist and anaesthetic team need a response that checks the whole chain rather than just escalating dose reflexively.

Confirm the intended dose was actually delivered.
Check whether the ACT system and sample handling are trustworthy.
Consider antithrombin deficiency or heavy pre-existing heparin exposure.
Interpret the result in the context of the patient, not as an isolated monitor number.

What a structured response looks like

Good teams usually move through the same sequence: verify the dose path, repeat or confirm the test, review the anticoagulation context, and then choose the next intervention according to protocol.

That next step may involve additional heparin, antithrombin replacement, or another protocol-defined strategy. The important point is that it should be deliberate and local-policy aligned, not ad hoc.

Why this is a perfusion teaching topic

Heparin resistance matters because it sits at the intersection of pharmacology, monitoring, and bypass readiness. It is also exactly the kind of event that unsettles trainees, because the room can drift into uncertainty quickly if nobody names the framework clearly.

An educational article gives learners the logic they need before they ever see the first resistant ACT in practice.

Practice rehearsal

Use this article to rehearse the verification sequence before the room is under pressure: confirm dose delivery, repeat the ACT thoughtfully, consider antithrombin deficiency, and escalate by local protocol.